Trial · NCT00501059
Adverse events2,008
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,008
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 653 | 6,276 | 803 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Acetylsalicylic Acid | 636 | 6,270 | 816 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 688 | 6,276 | 908 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Acetylsalicylic Acid | 695 | 6,270 | 897 |
| other | Bronchitis | Infections and infestations | Placebo | 482 | 6,276 | 680 |
| other | Bronchitis | Infections and infestations | Acetylsalicylic Acid | 514 | 6,270 | 741 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo | 497 | 6,276 | 601 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Acetylsalicylic Acid | 442 | 6,270 | 556 |
| other | Dyspepsia | Gastrointestinal disorders | Placebo | 362 | 6,276 | 419 |
| other | Dyspepsia | Gastrointestinal disorders | Acetylsalicylic Acid | 374 | 6,270 | 446 |
| other | Hypertension | Vascular disorders | Placebo | 514 | 6,276 | 578 |
| other | Hypertension | Vascular disorders | Acetylsalicylic Acid | 478 | 6,270 | 526 |
| other | Lower respiratory tract infection | Infections and infestations | Placebo | 420 | 6,276 | 703 |
| other | Lower respiratory tract infection | Infections and infestations | Acetylsalicylic Acid | 377 | 6,270 | 650 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 407 | 6,276 | 524 |
| other | Nasopharyngitis | Infections and infestations | Acetylsalicylic Acid | 421 | 6,270 | 550 |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Placebo | 423 | 6,276 | 517 |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Acetylsalicylic Acid | 468 | 6,270 | 548 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 359 | 6,276 | 406 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Acetylsalicylic Acid | 354 | 6,270 | 406 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00501059/events